Food & Beverages company EID Parry (India) announced Q4FY25 & FY25 results Consolidated Q4FY25 Financial Highlights: The consolidated revenue from operations for the quarter ended 31st March 2025, was Rs 6,811 crore registering an increase of 23% in comparison to the corresponding quarter of the previous year of Rs5,557 crore. Earnings before interest, tax, depreciation and amortisation (EBITDA) (excluding exceptional items of Rs 347 crore) for the quarter ended 31st March 2025 was Rs 626 crore registering an increase of 8 % in comparison to the corresponding quarter of the previous year of Rs 581 crore. The consolidated profit after tax and non-controlling interest was Rs 287 crore as against Rs220 crore in the corresponding quarter of the previous year. Consolidated FY25 Financial Highlights: The consolidated revenue from operations for the year ended 31st March 2025 was Rs 31,609 crore as against Rs 29,413 crore in the previous year. Earnings before interest, tax, depreciation and amortisation (EBITDA) (excluding exceptional items of Rs 347 crore), for the year ended 31st March 2025 was Rs 2,992 crore as against Rs 2,891 crore in the previous year. Consolidated profit after tax and non-controlling interest was Rs 878 crore as compared to Rs 900 crore in the previous year. Standalone Q4FY25 Financial Highlights: The standalone revenue from operations for the quarter ended 31st March 2025 was Rs 814 crore in comparison to the corresponding quarter of previous year of Rs 717 crore. Earnings before interest, tax, depreciation and amortisation (EBITDA) for the quarter ended 31st March 2025 was of Rs225 crore (excluding exceptional item of Rs 350 crore) in comparison to the corresponding quarter of the previous year of Rs 166 crore. The standalone loss after tax for the quarter was Rs 232 crore (which includes a provision for impairment of investment in a subsidiary amounting to Rs 350 crore), as compared to a profit of Rs 80 crore in the corresponding quarter of the previous year. Standalone FY25 Financial Highlights: The standalone revenue from operations for the year ended ended 31st March 2025 was Rs 3,168 crore as against Rs 2,809 crore in the previous year. Earnings before interest, tax, depreciation and amortisation (EBITDA) for the year ended 31st March 2025 stood at Rs 251 crore (before exceptional item of Rs 427 crore) as compared to Rs 306 crore in the previous year. Standalone loss after tax for the year ended was Rs 428 crore (includes Rs 427 crore provision for impairment of investment in subsidiary) as compared to a profit of Rs 107 crore in the previous year. Muthiah Murugappan, Whole-time Director and Chief Executive Officer commented on the standalone results : Sugar: The revenues of the sugar segment for the current year were at Rs 1,571 crore as against Rs 1,809 crore in the previous year, registering a de-growth of 13% due to lower crushing which led to lower sugar production and consequently, a lower release quota. The sugar segment registered a loss of Rs 86 crore as compared to a profit of Rs 68 crore for the previous year on account of lower cane volume (38 LMT YTD Mar 25 Vs 50 LMT in YTD Mar 24), lower recoveries and higher cane cost. The sugar realizations increase were not in proportion to the increase in costs. Distillery: The revenues of the distillery segment for the current year were at Rs 1,102 crore as against Rs 799 crore in the previous year, registering a growth of 38%, benefitting from enhanced capacity utilisation after completion of distillery expansion projects. Although revenues witnessed an increase, the profitability remains under pressure due to higher input costs. Consumer Products Group (CPG): The Consumer Products Group (CPG) delivered revenues of Rs 884 crore for the current year, registering a growth of 65% over the previous year (Rs 535 crore) aided by an expanded product portfolio with the launch of Branded Staples. The Branded Sweetener category within the CPG delivered a steady performance, registering a growth of 11% over the previous year. Nutraceuticals: The revenues of the nutraceuticals segment for the current year were at Rs 37 crore as against Rs 31 crore in the previous year, registering an increase of 18%. The loss under this segment stood at Rs 1 crore compared to the previous year’s loss of Rs 10 crore on account of optimization of overheads and the commencement of exports to Europe consequent to receipt of the European certification. Result PDF